Scarica l'app Stockscreener
9.10
2.36%
-0.22
Dopo l'orario di chiusura:
9.10
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Perché GRFS Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Grifols Sa Adr Borsa (GRFS) Ultime notizie
Infectious Disease Diagnostics Market to Reach USD 43.09 Billion by 2031 | SkyQuest Technology - Benzinga
Is it possible to buy Grifols SA ADR(GRFS) shares at a good price now? - US Post News
Grifols SA ADR (GRFS)’s Day in Review: Closing at 8.58, Down by -0.12 - The Dwinnex
RFID Kanban Systems Market Forecast to Reach $9.53 Billion by 2030 - GlobeNewswire Inc.
A Look at Grifols SA ADR (GRFS) Shares in the Recent Past Indicates Growth - SETE News
Cboe Global Markets Inc. (AMEX: CBOE): Getting A Free Pass? - Stocks Register
It is Poised to be a Bull Market for Grifols SA ADR (GRFS) - SETE News
Grifols: Here Is Why It's Still A 'Buy' Even If Price Goes Down (NASDAQ:GRFS) - Seeking Alpha
Examining Grifols SA ADR (GRFS) stock is warranted - US Post News
Are Grifols SA ADR’shares a good deal? - US Post News
Financial Health Report: Grifols SA ADR (GRFS)’s Ratios Tell a Tale - The Dwinnex
Was anything negative for Grifols SA ADR (GRFS) stock last session? - US Post News
Ratio Review: Analyzing Grifols SA ADR (GRFS)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
GRFS’s Stock Market Puzzle: Piecing Together 2023’s Performance - The InvestChronicle
How does Grifols SA ADR (GRFS) change from a tortoise to a hare? - SETE News
Mexico Blood Transfusion Diagnostics Market Size & Outlook, 2027 - Grand View Research
The Significance of Moving Averages in Grifols SA ADR Inc. (GRFS) Price Performance - The InvestChronicle
Have you been able to find a good deal on Grifols SA ADR’s shares? - US Post News
Closing Figures: Grifols SA ADR (GRFS)’s Negative Finish at 8.41, Down -1.87 - The Dwinnex
A History of Outperforming Analyst Forecasts and Beating the Odds: Grifols SA ADR (GRFS) - SETE News
Analytical Overview: Grifols SA ADR (GRFS)’s Ratios Tell a Financial Story - The Dwinnex
Investing in Grifols SA ADR (GRFS) might be an excellent idea, but the stock is currently overvalued/undervalued - US Post News
Grifols Class B stock falls as Brookfield reportedly seeks lower price - MSN
Grifols Class B stock discounted by Brookfield (NASDAQ:GRFS) - Seeking Alpha
An analyst sees good growth prospects for Grifols SA ADR (GRFS) - SETE News
Grifols SA ADR [GRFS] Is Currently 1.11 below its 200 Period Moving Avg: What Does This Mean? - The DBT News
Grifols SA ADR (GRFS)’s Market Momentum: Closing Strong at 9.00, Up 2.74 - The Dwinnex
Grifols SA ADR (GRFS) looking to reclaim success with recent performance - SETE News
Why Grifols (GRFS) Stock Price Moved Up 7% on Wednesday - Yahoo Finance
Is the Grifols SA ADR (NASDAQ:GRFS) stock an investment opportunity? - US Post News
Get in on Grifols SA ADR’s (GRFS) buy-in window today! - SETE News
Grofols stock gains as Brookfield eyes takeover (NASDAQ:GRFS) - Seeking Alpha
Market Update: Grifols SA ADR (GRFS) Sees Positive Movement, Closing at 7.18 - The Dwinnex
XPeng Inc. Sponsored ADR (XPEV) Laps the Stock Market: Here's Why - Yahoo Finance
How did Grifols SA ADR (GRFS) fare last session? - US Post News
Ratios Revealed: Decoding Grifols SA ADR (GRFS)’s Financial Health - The Dwinnex
Grifols SA ADR: A Comprehensive Look at the Stock’s Ups and Downs - The InvestChronicle
Are Investors Inclined To Sell Their Bath & Body Works Inc (NYSE: BBWI) Holdings? - Stocks Register
Does Uranium Royalty Corp (NASDAQ: UROY) Still Need To Convince Analysts? - Stocks Register
What Do Wall Street Analysts Think About Tetra Technologies, Inc. (NYSE: TTI) Stock? - Stocks Register
What Did We Find About Insider Trading At Monster Beverage Corp. (NASDAQ: MNST)? - Stocks Register
The growth track for Grifols SA ADR (GRFS) has changed recently - SETE News
India Blood Transfusion Diagnostics Market Size & Outlook, 2027 - Grand View Research
Investing in Grifols SA ADR (GRFS) might be a great opportunity, but the stock is a bit overvalued - US Post News
Validea Joseph Piotroski Strategy Daily Upgrade Report8/6/2024 - Nasdaq
Grifols SA ADR’s Bumpy Road: Analyzing the 52-Week Range and Future Prospects - The InvestChronicle
Our Attention Has Been Attracted to Grifols SA ADR (NASDAQ:GRFS) - US Post News
Grifols revises past financial records with equity value drop of $494 mln - Marketscreener.com
Grifols SA ADR (GRFS) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - SETE News
You might want to take a look at Grifols SA ADR (GRFS) now - SETE News
A stock that deserves closer examination: Grifols SA ADR (GRFS) - US Post News
Grifols SA ADR (NASDAQ: GRFS): Should Value Hunters Buy It? - Stocks Register
Market Insight: Grifols SA ADR (GRFS)’s Notable Drop, Closing at 8.16 - The Dwinnex
There is no way Grifols SA ADR (GRFS) can keep these numbers up - SETE News
Grifols: Going Private? Brookfield On The Scene (OTCMKTS:GIFLF) - Seeking Alpha
Grifols SA ADR (GRFS) Stock: Navigating a Year of Volatility - The InvestChronicle
Daily Market Movement: Grifols SA ADR (GRFS) Sees a 6.45 Increase, Closing at 8.91 - The Dwinnex
Is Grifols SA ADR (GRFS) a good investment opportunity? - US Post News
A better buy-in window may exist right now for Grifols SA ADR (GRFS) - SETE News
GRFS’s 2023 Market Dance: Down -26.38% – Time to Invest? - The InvestChronicle
Grifols receives takeover interest from its founding family, Brookfield fund; to go private - Seeking Alpha
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)? - Yahoo Canada Shine On
Grifols SA ADR (GRFS) looking to reclaim success with recent performance – Sete News - SETE News
2.76%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):